抗凝血酶III在产科DIC患者中的效果:日本全国性观察研究
本研究利用日本全国住院数据库,纳入2010年7月至2018年3月分娩并诊断DIC的9920例患者,经倾向评分匹配比较使用与未使用抗凝血酶III(ATIII)者的院内死亡和子宫切除。结果显示ATIII未显著降低院内死亡率(0.3% vs 0.5%,OR 0.73,95%CI 0.35-1.54),但子宫切除比例显著降低(5.3% vs 8.7%,绝对风险差-2.9%,95%CI -4.2至-1.6%)。
要点
- ATIII未显著降低产科DIC患者的院内死亡率。
- ATIII组子宫切除比例显著低于对照组(5.3% vs 8.7%)。
- ATIII可能通过减少子宫切除带来临床获益。
核心结论
- ATIII未显示降低产科DIC患者院内死亡率的效应,但可能减少子宫切除。
研究设计与样本
- 日本全国性观察研究,使用诊断程序组合住院数据库,纳入2010年7月至2018年3月分娩并诊断DIC的患者9920例,其中ATIII使用组4329例(44%),未使用组5511例(56%),经1:1倾向评分匹配形成3290对。
主要发现
- 倾向匹配后院内 maternal mortality 在ATIII组为0.3%,对照组为0.5%,比值比0.73(95%CI 0.35-1.54),差异无统计学意义。
- ATIII组住院期间子宫切除比例为5.3%,对照组为8.7%,绝对风险差-2.9%(95%CI -4.2至-1.6%),差异显著。
临床怎么用
- 对于产科DIC患者,ATIII虽未证实降低死亡率,但可考虑用于减少子宫切除风险。
局限性
- 本研究为观察性研究,存在未测量混杂可能,倾向评分匹配仅控制已测量变量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pregnant women may develop disseminated intravascular coagulation (DIC), possibly resulting in massive maternal haemorrhage and perinatal death. The Japan guideline recommends use of antithrombin III (ATIII) for DIC in obstetrics; however, its effect remains uncertain. The present study aimed to investigate the effect of ATIII for DIC in obstetrics, using a national inpatient database in Japan. DESIGN: Nationwide observational study. SETTING: Japan. POPULATION: We used the Diagnosis Procedure Combination inpatient database to identify patients who delivered at hospital and were diagnosed with DIC from July 2010 to March 2018. METHODS: Propensity score matching analyses were performed to compare in-hospital maternal mortality and hysterectomy during hospitalisation between users and non-users of ATIII on the day of delivery. MAIN OUTCOME MEASURES: In-hospital mortality, hysterectomy. RESULTS: A total of 9920 patients were enrolled, including 4329 patients (44%) who used ATIII and 5511 patients (56%) who did not use ATIII. One-to-one propensity score matching created 3290 pairs. In-hospital maternal mortality did not differ significantly between the propensity-matched groups (0.3% in the ATIII group versus 0.5% in the control group; odds ratio 0.73; 95% CI 0.35-1.54). A significantly lower proportion of patients in the ATIII group, compared with those in the control group, underwent hysterectomy during hospitalisation (5.3% versus 8.7%; absolute risk difference -2.9%; 95% CI -4.2 to -1.6%). CONCLUSIONS: Although the present study did not show a mortality-reducing effect of ATIII for patients with DIC in obstetrics, it may have clinical benefit in terms of reducing the number of patients undergoing hysterectomy. TWEETABLE ABSTRACT: This study did not show mortality-reducing effect of antithrombin III for patients with DIC in obstetrics.
引用
- Iwasaki Y, Ohbe H, Shigemi D, et al. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: a nationwide observational study in Japan. BJOG. 2021. PMID: 34545675. doi:10.1111/1471-0528.16938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。